| |
| |
|
| Insider
Information: |
Davis Stephen |
| Relationship: |
Director |
| City: |
Branford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
333,153 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,548,410 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
333,153 |
|
|
| Total
Value |
$2,548,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -87.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Heron Therapeutics Inc |
HRTX |
Director |
2022-12-16 |
52,032 |
2010-02-17 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
EVP & COO |
2012-06-19 |
0 |
2010-04-06 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-05-24 |
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-04-08 |
144,267 |
2019-10-09 |
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
136,854 |
2022-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-04-08 |
4 |
AS |
$17.87 |
$474,877 |
D/D |
(26,574) |
144,267 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,999 |
170,841 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-03-27 |
4 |
AS |
$17.90 |
$317,081 |
D/D |
(17,714) |
118,842 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
34,666 |
136,556 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-02-26 |
4 |
AS |
$24.67 |
$137,585 |
D/D |
(5,577) |
101,890 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,946 |
107,467 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-01-08 |
4 |
S |
$29.96 |
$111,811 |
D/D |
(3,732) |
96,521 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,528 |
100,253 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-10-06 |
4 |
S |
$21.96 |
$1,132,323 |
D/D |
(51,563) |
89,131 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
103,999 |
140,694 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-07-14 |
4 |
AS |
$30.04 |
$3,004,350 |
D/D |
(100,000) |
36,695 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-07-14 |
4 |
OE |
$20.77 |
$2,077,000 |
D/D |
100,000 |
136,695 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-07-12 |
4 |
AS |
$25.05 |
$1,380,449 |
D/D |
(55,104) |
36,695 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-07-11 |
4 |
AS |
$25.00 |
$412,450 |
D/D |
(16,498) |
91,799 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-05-01 |
4 |
S |
$21.18 |
$165,331 |
D/D |
(7,806) |
108,297 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,625 |
116,103 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-04-06 |
4 |
S |
$18.16 |
$155,849 |
D/D |
(8,582) |
100,478 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,333 |
109,060 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-02-24 |
4 |
S |
$18.78 |
$72,322 |
D/D |
(3,851) |
91,727 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,945 |
95,578 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-01-09 |
4 |
S |
$17.13 |
$66,877 |
D/D |
(3,904) |
84,633 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,528 |
88,537 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
74,739 |
136,854 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
38,580 |
52,032 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2022-10-15 |
4 |
S |
$15.81 |
$44,331 |
D/D |
(2,804) |
79,009 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
